SRTS
Sensus Healthcare, Inc.NASDAQHealthcare$4.11+2.92%ClosedMarket Cap: $67.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.44
P/S
2.53
EV/EBITDA
-7.19
DCF Value
$1.10
FCF Yield
0.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
43.2%
Operating Margin
-37.5%
Net Margin
-28.1%
ROE
-15.1%
ROA
-14.6%
ROIC
-17.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $4.9M | 38.4% | $-3.1M | $-3.2M | $-0.19 | — |
| FY 2025 | $27.5M | 43.2% | $-10.3M | $-7.7M | $-0.47 | — |
| Q3 2025 | $6.9M | 39.4% | $-2.6M | $-943.0K | $-0.06 | — |
| Q2 2025 | $7.3M | 39.7% | $-1.9M | $-1.0M | $-0.06 | — |
| Q1 2025 | $8.3M | 52.2% | $-2.6M | $-2.6M | $-0.16 | — |
| Q4 2024 | $13.1M | 54.4% | $1.7M | $1.5M | $0.09 | — |
| FY 2024 | $41.8M | 58.4% | $8.1M | $6.6M | $0.41 | — |
| Q3 2024 | $8.8M | 59.3% | $1.5M | $1.2M | $0.07 | — |
| Q2 2024 | $9.2M | 58.7% | $2.0M | $1.6M | $0.10 | — |
| Q1 2024 | $10.7M | 62.5% | $2.9M | $2.3M | $0.14 | — |
| Q4 2023 | $12.6M | 62.3% | $5.6M | $4.2M | $0.26 | — |
| FY 2023 | $24.4M | 57.6% | $-382.0K | $485.0K | $0.03 | — |